Among First Companies to Natively Integrate Software Applications;
Gives
Eclipsys Clients Choice and Lower Total Cost of Ownership
ATLANTA, Mar 29, 2010 (BUSINESS WIRE) --Following the momentum of launching an industry-defining open
architecture platform, Eclipsys Corporation (NASDAQ: ECLP) today
announced a partnership with Rothman Healthcare Research (Rothman) to
build its Patient Condition Tracker software solution on the Helios by
Eclipsys(TM) platform. The resulting native integration will give the
Eclipsys hospital client base the option to utilize Rothman's
third-party patient condition monitoring tool in an integrated
environment with the Eclipsys Sunrise Enterprise(TM) suite of
solutions--without the additional time and expense typically required to
interface disparate software applications.
"Eclipsys and Rothman share a long-standing relationship to improve
patient care, and we both agree that the most effective way to achieve
technology adoption in healthcare is through vendor neutrality," said
Daniel Rothman, executive vice president of Rothman Healthcare Research.
"Rothman Healthcare Research was formed to turn a negative into a
positive, developing our Patient Condition Tracker tool after a family
member died from undetected complications following a medical procedure.
The release of Helios by Eclipsys(TM) gives small dynamic companies like
ours the enhanced ability to drive innovation in health information
technology. There are many good ideas in the market, but hospitals are
typically risk adverse for unknown applications from smaller vendors.
The ability to have an open platform from an enterprise vendor like
Eclipsys can accelerate the pace of innovation and adoption of newer,
better ideas and offerings."
Since 2004, Rothman Healthcare Research has been developing the Patient
Condition Tracker to bridge the gaps in continuity of care. Rothman's
software application uses electronic health record (EHR) data to
highlight subtle declines in patient health and immediately alert
physicians in snapshot form. Patient records are coded in colors for
nurses to more easily understand patient conditions. The software
application is fed data from the hospital's existing EHR system to
generate and display a health score, based on vital signs, nursing
assessments and lab results, in a user-friendly graphical format. The
software also offers medical personnel the ability to see multiple
patient graphs simultaneously for a high-level understanding of a whole
unit.
"Rothman's Patient Condition Tracker is an innovative solution that was
specifically designed to help send more patients home safely," said
Philip M. Pead, president and chief executive officer of Eclipsys. "Yet
in the risk-adverse healthcare industry, many hospitals have been
reluctant to adopt a new technology from a smaller vendor, even though
it could lead to better patient outcomes and workflow efficiencies.
Rothman's business story is a prime example of why we have opened up our
platform to enable clients and companies to natively write applications.
It delivers choice and great benefits to our clients who want to use the
Rothman solution. It will eliminate the need for interfaces, lower the
total cost of technology ownership and give their clinicians an
additional monitoring tool to support patient safety."
"We are excited to work with Rothman Healthcare Research," added Pead,
"Since we announced our Helios by Eclipsys(TM) platform on March 1, we have
been approached by several hundred companies who have expressed an
interest in integrating their applications on our platform. Eclipsys'
open architecture provides true choice for our clients and eliminates
the need for cumbersome and costly interfaces."
About Rothman Healthcare Research, LLC
Rothman Healthcare Research is committed to improving the quality and
efficiency of patient care with innovative, patient-centric software
that enables healthcare professionals to easily access critical and
actionable patient health data. The Patient Condition Tracker generates
a graph of patient condition that allows for greater continuity and
quality of care while reducing costs. For more information, see www.rothmanhealthcare.com.
About Eclipsys
Eclipsys is a leading provider of advanced integrated clinical, revenue
cycle and performance management software, clinical content and
professional services that help healthcare organizations improve
clinical, financial and operational outcomes. For more information, see www.eclipsys.com
or email info@eclipsys.com.
To view more about Helios by Eclipsys(TM), see www.YouTube.com/EclipsysTV.
Statements in this news release concerning the scope of the agreement
between Eclipsys and Rothman and features of and benefits provided by
Eclipsys software and the application development by third parties,
including Rothman, are forward-looking statements and actual results may
differ from those projected due to a variety of risks and uncertainties.
Implementation and customization of Eclipsys software is complex and
time-consuming. The open platform initiative is new and untested in the
market, and integration of third party systems will require additional
development. Results depend upon a variety of factors and can vary by
client. Each client's circumstances are unique and may include
unforeseen issues that make it more difficult than anticipated to
implement or derive benefit from Eclipsys software or services. The
success and timeliness of the company's services will depend at least in
part upon client involvement, which can be difficult to control. The
agreement between Eclipsys and Rothman can be terminated or its scope
reduced under certain circumstances. More information about company
risks is available in recent Form 10-Q and 10-K filings made by Eclipsys
from time to time with the Securities and Exchange Commission. Special
attention is directed to the portions of those documents entitled "Risk
Factors" and "Management's Discussion and Analysis of Financial
Condition and Results of Operations." Eclipsys, Helios by Eclipsys, and
Sunrise Enterprise are either registered trademarks or trademarks of
Eclipsys Corporation (or its subsidiaries) in the United States and
certain other countries. Other product and company names in this news
release are or may be trademarks of their respective companies.
SOURCE: Eclipsys Corporation
Eclipsys:
Robin Wrinn, 404-847-5219
Director, Public Relations
(media)
robin.wrinn@eclipsys.com
or
Jason Cigarran, 404-847-5965
Vice President, Investor Relations
jason.cigarran@eclipsys.com
or
Rothman Healthcare Research:
Eddie Saade
Senior Director, Development
eddie@rothmanhealthcare.com
